Literature DB >> 23285439

The Immunohistochemical Expression of the Oestrogen Receptor (ER), HER-2/NEU and Cytokeratin 8/18 and 5/6 in Invasive Breast Carcinoma.

Bharti Rattan1, Mridu Manjari, S K Kahlon, Nikita Kalra, Amarpreet Bhalla, Surinder Paul.   

Abstract

INTRODUCTION: Carcinoma is the most common malignancy of the breast and breast cancer is the most common non-skin malignancy in women. Ideally, prevention or very early detection of breast cancer reduce both morbidity and mortality of the disease. Effective use of tumour markers might permit the application of screening and treatment more efficiently.
MATERIALS AND METHODS: Immunohistochemical study was done in 39 cases of invasive breast carcinoma for further sub-classification for predicting prognosis and therapeutic approach. The cases were evaluated for expression of cytokeratin Ck 8/18, ER & Her-2/neu and 28 cases were subjected to cytokeratin Ck 5/6 including especially the cases negative for all the three markers.
RESULTS: ER was positive in seven cases with Her-2/neu being positive in eight cases and cytokeratin 8/18 positive in 33 cases. Cytokeratin 5/6 was positive in seven cases with four cases showing Ck 5/6 and Ck8/18 positivity, three cases showing positivity for Ck 5/6 only and three cases were negative for all the four markers.
CONCLUSION: Thus classifying them to be luminal A, luminal B, combined, basal and null type respectively. Luminal A tmours show the best prognosis while luminal B tumours , combined , basal and null type are associated with less favouable outcome. Thus it is important to categorise them according to the cell of origin for prognosis and treatment.

Entities:  

Keywords:  Immunohistochemistry; Infiltrating ductal carcinoma; Monoclonal antibodies

Year:  2012        PMID: 23285439      PMCID: PMC3527779          DOI: 10.7860/JCDR/2012/4086.2542

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  17 in total

1.  Significance of p53 and Bcl-2 Protein Expression in Human Breast Ductal Carcinoma.

Authors: 
Journal:  Cancer Control       Date:  1999-03       Impact factor: 3.302

2.  Assessment of HER2/Neu status by fluorescence in situ hybridization in immunohistochemistry-equivocal cases of invasive ductal carcinoma and aberrant signal patterns: a study at a tertiary cancer center.

Authors:  Sudha S Murthy; D G Sandhya; Faiq Ahmed; K Iravathy Goud; Monal Dayal; K Suseela; Senthil J Rajappa
Journal:  Indian J Pathol Microbiol       Date:  2011 Jul-Sep       Impact factor: 0.740

3.  Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.

Authors:  Arvydas Laurinavicius; Aida Laurinaviciene; Valerijus Ostapenko; Darius Dasevicius; Sonata Jarmalaite; Juozas Lazutka
Journal:  Diagn Pathol       Date:  2012-03-16       Impact factor: 2.644

4.  Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells.

Authors:  R B Nagle; W Böcker; J R Davis; H W Heid; M Kaufmann; D O Lucas; E D Jarasch
Journal:  J Histochem Cytochem       Date:  1986-07       Impact factor: 2.479

5.  Keratin expression in the normal breast and in breast carcinoma.

Authors:  A Tsubura; H Okada; H Senzaki; T Hatano; S Morii
Journal:  Histopathology       Date:  1991-06       Impact factor: 5.087

6.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

7.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

8.  Hormone receptor status of breast cancer in India: a study of 798 tumours.

Authors:  S B Desai; M T Moonim; A K Gill; R S Punia; K N Naresh; R F Chinoy
Journal:  Breast       Date:  2000-10       Impact factor: 4.380

9.  Complex cytokeratin polypeptide patterns observed in certain human carcinomas.

Authors:  R Moll; R Krepler; W W Franke
Journal:  Differentiation       Date:  1983       Impact factor: 3.880

Review 10.  Expression profiling technology: its contribution to our understanding of breast cancer.

Authors:  E A Rakha; M E El-Sayed; J S Reis-Filho; I O Ellis
Journal:  Histopathology       Date:  2008-01       Impact factor: 5.087

View more
  1 in total

1.  Prognostic Significance of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) in Epithelial Ovarian Cancer.

Authors:  Gwan Hee Han; Doo Byung Chay; Sanghee Nam; Hanbyoul Cho; Joon-Yong Chung; Jae-Hoon Kim
Journal:  Cancer Genomics Proteomics       Date:  2020 May-Jun       Impact factor: 4.069

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.